Company

Anumana

vendor1 tracked tool

imaging_diagnostics category intelligence

Tracked Tools by Anumana

Anumana is an AI-driven health technology company specializing in ECG-based algorithms for early detection of cardiovascular diseases, including low ejection fraction.

Company Intelligence

Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

5 months agofda

Anumana Announces Issuance of New American Medical Association CPT® Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction

5 months agodeployment

Anumana is advancing early detection of cardiovascular disease by embedding clinically validated AI directly into routine ECG workflows, supporting decision-making from primary care through cardiac subspecialty settings.

5 months agoevidence

Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

5 months agodeployment

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

5 months agofda

Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

5 months agofda

Anumana Receives FDA Breakthrough Device Designation for Cardiac Amyloidosis Algorithm

5 months agofda

Why The Federal Government Wants Agentic AI To Treat Heart Failure

5 months agodeployment